Avidity Partners Management LP Purchases New Position in Acadia Healthcare Company, Inc. $ACHC

Avidity Partners Management LP purchased a new stake in Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 169,000 shares of the company’s stock, valued at approximately $2,398,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. EverSource Wealth Advisors LLC lifted its position in Acadia Healthcare by 54.8% in the second quarter. EverSource Wealth Advisors LLC now owns 1,404 shares of the company’s stock valued at $32,000 after acquiring an additional 497 shares during the last quarter. Federated Hermes Inc. lifted its position in Acadia Healthcare by 1.5% in the fourth quarter. Federated Hermes Inc. now owns 43,913 shares of the company’s stock valued at $623,000 after acquiring an additional 668 shares during the last quarter. Public Employees Retirement System of Ohio lifted its position in Acadia Healthcare by 2.8% in the third quarter. Public Employees Retirement System of Ohio now owns 31,335 shares of the company’s stock valued at $776,000 after acquiring an additional 867 shares during the last quarter. Treasurer of the State of North Carolina lifted its position in Acadia Healthcare by 2.1% in the second quarter. Treasurer of the State of North Carolina now owns 42,502 shares of the company’s stock valued at $964,000 after acquiring an additional 867 shares during the last quarter. Finally, Teachers Retirement System of The State of Kentucky lifted its position in Acadia Healthcare by 1.5% in the third quarter. Teachers Retirement System of The State of Kentucky now owns 79,730 shares of the company’s stock valued at $1,974,000 after acquiring an additional 1,141 shares during the last quarter.

Acadia Healthcare Price Performance

Shares of NASDAQ:ACHC opened at $24.60 on Friday. The company has a 50-day simple moving average of $25.52 and a 200-day simple moving average of $20.04. Acadia Healthcare Company, Inc. has a one year low of $11.43 and a one year high of $30.20. The company has a debt-to-equity ratio of 1.27, a quick ratio of 1.71 and a current ratio of 1.71. The stock has a market capitalization of $2.26 billion, a price-to-earnings ratio of -2.01, a PEG ratio of 8.20 and a beta of 0.69.

Acadia Healthcare (NASDAQ:ACHCGet Free Report) last announced its earnings results on Wednesday, April 29th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.28 by $0.09. Acadia Healthcare had a negative net margin of 32.84% and a positive return on equity of 7.09%. The business had revenue of $828.80 million during the quarter, compared to analysts’ expectations of $823.51 million. During the same period in the prior year, the company earned $0.40 earnings per share. The business’s revenue was up 7.6% compared to the same quarter last year. Acadia Healthcare has set its Q2 2026 guidance at 0.300-0.400 EPS. On average, analysts predict that Acadia Healthcare Company, Inc. will post 1.5 EPS for the current year.

Analysts Set New Price Targets

A number of brokerages recently weighed in on ACHC. UBS Group boosted their price target on shares of Acadia Healthcare from $27.00 to $31.00 and gave the company a “buy” rating in a research report on Friday, April 17th. KeyCorp reissued an “overweight” rating and issued a $30.00 price target on shares of Acadia Healthcare in a research report on Wednesday, May 27th. Cantor Fitzgerald boosted their price target on shares of Acadia Healthcare from $20.00 to $30.00 and gave the company a “neutral” rating in a research report on Friday, May 1st. Zacks Research raised shares of Acadia Healthcare from a “strong sell” rating to a “hold” rating in a report on Thursday, March 5th. Finally, TD Cowen upped their target price on shares of Acadia Healthcare from $24.00 to $30.00 and gave the company a “buy” rating in a report on Tuesday, April 28th. One research analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, five have given a Hold rating and two have assigned a Sell rating to the stock. According to data from MarketBeat, Acadia Healthcare presently has a consensus rating of “Hold” and a consensus target price of $26.85.

View Our Latest Report on ACHC

Acadia Healthcare Profile

(Free Report)

Acadia Healthcare Company, Inc (NASDAQ: ACHC) is a publicly traded provider of behavioral healthcare services headquartered in Franklin, Tennessee. Founded in 2005, the company has grown through organic expansion and strategic acquisitions to establish itself as a leading specialist in mental health and addiction treatment across the United States.

Acadia operates a diversified network of inpatient psychiatric hospitals, residential treatment centers, outpatient clinics and intensive outpatient programs.

Featured Stories

Want to see what other hedge funds are holding ACHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Acadia Healthcare Company, Inc. (NASDAQ:ACHCFree Report).

Institutional Ownership by Quarter for Acadia Healthcare (NASDAQ:ACHC)

Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.